Annual Total Long Term Liabilities
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 7, 2025, AVXL annual total long term liabilities is $0.00, unchanged on September 30, 2024.
- During the last 3 years, AVXL annual total long term liabilities has risen by $0.00 (0.00%).
- AVXL annual total long term liabilities is now -100.00% below its all-time high of $5.72 million, reached on September 30, 2014.
Performance
AVXL Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 7, 2025, AVXL quarterly total long term liabilities is $0.00, unchanged on September 30, 2024.
- Over the past year, AVXL quarterly long term liabilities has stayed the same.
- AVXL quarterly long term liabilities is now -100.00% below its all-time high of $5.72 million, reached on September 30, 2014.
Performance
AVXL Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AVXL Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | 0.0% | 0.0% |
| 3 y3 years | 0.0% | 0.0% |
| 5 y5 years | 0.0% | 0.0% |
AVXL Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | at low |
| 5 y | 5-year | at high | at low | at high | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low |
Anavex Life Sciences Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | - | $0.00(0.0%) |
| Sep 2023 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) |
| Dec 2022 | - | $0.00(0.0%) |
| Sep 2022 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) |
| Dec 2021 | - | $0.00(0.0%) |
| Sep 2021 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2021 | - | $0.00(0.0%) |
| Mar 2021 | - | $0.00(0.0%) |
| Dec 2020 | - | $0.00(0.0%) |
| Sep 2020 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00(0.0%) |
| Dec 2019 | - | $0.00(0.0%) |
| Sep 2019 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | - | $0.00(0.0%) |
| Sep 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | - | $0.00(0.0%) |
| Sep 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | $0.00(-100.0%) | $0.00(-100.0%) |
| Jun 2016 | - | $300.00(0.0%) |
| Mar 2016 | - | $300.00(0.0%) |
| Dec 2015 | - | $300.00(0.0%) |
| Sep 2015 | $300.00(-100.0%) | $300.00(-99.5%) |
| Jun 2015 | - | $58.00 K(-56.6%) |
| Mar 2015 | - | $133.70 K(-97.4%) |
| Dec 2014 | - | $5.16 M(-9.8%) |
| Sep 2014 | $5.72 M(+532.7%) | $5.72 M(>+9900.0%) |
| Jun 2014 | - | $1100.00(+10.0%) |
| Mar 2014 | - | $1000.00(>+9900.0%) |
| Dec 2013 | - | $0.00(-100.0%) |
| Sep 2013 | $904.00 K(>+9900.0%) | $904.00 K(>+9900.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | - | $0.00(0.0%) |
| Sep 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | - | $0.00(0.0%) |
| Sep 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | - | $0.00(0.0%) |
| Sep 2010 | $0.00(-100.0%) | $0.00(-100.0%) |
| Jun 2010 | - | $963.40 K(-16.6%) |
| Mar 2010 | - | $1.16 M(+831.8%) |
| Dec 2009 | - | $124.00 K(-26.2%) |
| Sep 2009 | $168.00 K(>+9900.0%) | $168.00 K(>+9900.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | - | $0.00 |
| Sep 2004 | $0.00 | - |
FAQ
- What is Anavex Life Sciences annual total long term liabilities?
- What is the all time high annual total long term liabilities for Anavex Life Sciences?
- What is Anavex Life Sciences annual total long term liabilities year-on-year change?
- What is Anavex Life Sciences quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Anavex Life Sciences?
- What is Anavex Life Sciences quarterly long term liabilities year-on-year change?
What is Anavex Life Sciences annual total long term liabilities?
The current annual total long term liabilities of AVXL is $0.00
What is the all time high annual total long term liabilities for Anavex Life Sciences?
Anavex Life Sciences all-time high annual total long term liabilities is $5.72 M
What is Anavex Life Sciences annual total long term liabilities year-on-year change?
Over the past year, AVXL annual total long term liabilities has changed by $0.00 (0.00%)
What is Anavex Life Sciences quarterly total long term liabilities?
The current quarterly long term liabilities of AVXL is $0.00
What is the all time high quarterly long term liabilities for Anavex Life Sciences?
Anavex Life Sciences all-time high quarterly total long term liabilities is $5.72 M
What is Anavex Life Sciences quarterly long term liabilities year-on-year change?
Over the past year, AVXL quarterly total long term liabilities has changed by $0.00 (0.00%)